EN
HI
Glaxosmithkline Pharmaceuticals share price chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
51205.00
Market Cap
43532.27 CR
LTQ@LTP
5@2569.70
ATP
2595.52
Var Margin
15.24 %
Circuit Range
2117.6-3176.4
Delivery %
50.16 %
Value
13.29 CR
ASM/GSM
No
Market Lot
1
Summary
GLAXO stock price is ₹2569.7 as of 5 Aug, 2026. The stock intraday movement has stayed between ₹2515.00 and ₹2650.20, while Glaxosmithkline Pharmaceuticals share price 52 week high low is ₹2088.10 & ₹3198.10.
In terms of trading activity, GLAXO share price has recorded a volume of 51,205 shares. The Glaxosmithkline Pharmaceuticals has a market cap of ₹169406034. The stock’s Average Traded Price (ATP) stands at ₹2595.52, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5 @ ₹2569.70.
The Glaxosmithkline Pharmaceuticals upper circuit limit is ₹3176.40 & The Glaxosmithkline Pharmaceuticals lower circuit limit is ₹2117.60, with a Value of ₹13.29 CR. The Delivery Percentage for the day is 50.16%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
41.99
P/B Ratio
17.8
Div. Yield
2.15
Sector P/E
64.89
Sector P/B
3.24
Sec. Div. Yield
0.52
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2644.1
Resistance
First Resistance
2686.9
Second Resistance
2726.8
Third Resistance
2769.6
Support
First Support
2604.2
Second Support
2561.4
Third Support
2521.5
Glaxosmithkline Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 05 2026 | 2648 | 2569.7 | -2.92% | 2650.2 | 2515 |
| Tue Aug 04 2026 | 2680.19 | 2647 | -0.57% | 2684 | 2601.3 |
| Mon Aug 03 2026 | 2665.39 | 2662.3 | 0.26% | 2670 | 2630 |
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
| 2024-10-29 | Quarterly Results & Interim Dividend |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in Directorate
GlaxoSmithKline Pharmaceuticals re-appointed Mr. Bhushan Akshikar as Managing Director for two years effective from December 1, 2026. The board also appointed Ms. Karine J F Natland as a Non-Executive Director and noted the resignation of Mr. Subesh Williams.
Aug 03 2026 16:11:36
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
GlaxoSmithKline Pharmaceuticals delivered strong Q1 FY27 performance with PAT growing 24% to Rs.253 crores and revenue up 15% to Rs.924 crores. This growth was driven by strong performance across its core and innovative portfolios including general medicines, vaccines, and oncology.
Aug 03 2026 16:10:43
Read More
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Alkem Laboratories Ltd.
5696.50
88.50 (1.58%)
Glenmark Pharmaceuticals Ltd.
2259.00
34.00 (1.53%)
Abbott India Ltd.
27785.00
-40.00 (0.14%)
Anthem Biosciences Ltd.
825.65
6.40 (0.78%)
Ajanta Pharma Ltd.
3437.50
-87.60 (2.49%)
Ipca Laboratories Ltd.
1765.00
70.30 (4.15%)
Gland Pharma Ltd.
2545.10
-38.00 (1.47%)
Narayana Hrudayalaya Ltd.
1903.10
-16.30 (0.85%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2569.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 41.99. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 17.8. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.89 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 43532.27 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3198.10 & 2088.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
